Open Access

Effects of neoadjuvant chemotherapy combined with radiotherapy in patients with advanced esophageal carcinoma

  • Authors:
    • Yu Liu
    • Deyao Xie
    • Chang Li
    • Chaoxi Lin
    • Jun Zhao
  • View Affiliations

  • Published online on: July 3, 2017     https://doi.org/10.3892/ol.2017.6515
  • Pages: 2803-2807
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We analyzed the improvement of survival time and the effects of neoadjuvant chemotherapy combined with radiotherapy on treating patients with advanced esophageal carcinoma. Retrospectively, 43 patients were selected with esophageal carcinoma who were administered neoadjuvant chemotherapy combined with radiotherapy. According to gender, and tumor staging, the nearest neighbor matching was carried out. Eighty-six patients (1:2) who received neoadjuvant chemotherapy and 129 patients (1:3) who underwent surgery only were taken and compared for clinical outcomes. It was found that in the combination group, the median survival time was prolonged and the 1-year survival rate improved. The diameter of tumors was significantly reduced, and the surgical resection, margin negative and total effective rates improved. In addition, the recurrence rate significantly decreased, whereas quality of life scores significantly increased (p<0.05). The comparison of overall incidence of complications was not statistically significant (p>0.05). Tumor staging, location, and diameter after neoadjuvant therapy, as well as therapeutic regimen, treatment cycle, margin negative rate and effective rate were independent risk factors for significantly influencing survival outcomes and time (p<0.05). In conclusion, neoadjuvant chemotherapy combined with radiotherapy can be utilized to treat advanced esophageal carcinoma improve survival time and promote prognosis.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 14 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu Y, Xie D, Li C, Lin C and Zhao J: Effects of neoadjuvant chemotherapy combined with radiotherapy in patients with advanced esophageal carcinoma. Oncol Lett 14: 2803-2807, 2017
APA
Liu, Y., Xie, D., Li, C., Lin, C., & Zhao, J. (2017). Effects of neoadjuvant chemotherapy combined with radiotherapy in patients with advanced esophageal carcinoma. Oncology Letters, 14, 2803-2807. https://doi.org/10.3892/ol.2017.6515
MLA
Liu, Y., Xie, D., Li, C., Lin, C., Zhao, J."Effects of neoadjuvant chemotherapy combined with radiotherapy in patients with advanced esophageal carcinoma". Oncology Letters 14.3 (2017): 2803-2807.
Chicago
Liu, Y., Xie, D., Li, C., Lin, C., Zhao, J."Effects of neoadjuvant chemotherapy combined with radiotherapy in patients with advanced esophageal carcinoma". Oncology Letters 14, no. 3 (2017): 2803-2807. https://doi.org/10.3892/ol.2017.6515